Search

Roberto Velez

Supervisory Patent Examiner (ID: 2100, Phone: (571)272-8597 , Office: P/2662 )

Most Active Art Unit
2829
Art Unit(s)
2662, 3600, 2829, 2858
Total Applications
468
Issued Applications
291
Pending Applications
74
Abandoned Applications
134

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16398745 [patent_doc_number] => 20200339603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection [patent_app_type] => utility [patent_app_number] => 16/862442 [patent_app_country] => US [patent_app_date] => 2020-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67763 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862442 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/862442
Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection Apr 28, 2020 Abandoned
Array ( [id] => 17733208 [patent_doc_number] => 20220218667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => DUAL INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/605525 [patent_app_country] => US [patent_app_date] => 2020-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605525 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/605525
DUAL INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE AND METHODS OF USE THEREOF Apr 23, 2020 Abandoned
Array ( [id] => 16397184 [patent_doc_number] => 20200338042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => USE OF DAPHNETIN IN TREATMENT OF AGE-RELATED COGNITIVE DECLINE [patent_app_type] => utility [patent_app_number] => 16/854910 [patent_app_country] => US [patent_app_date] => 2020-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2529 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854910 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/854910
USE OF DAPHNETIN IN TREATMENT OF AGE-RELATED COGNITIVE DECLINE Apr 21, 2020 Abandoned
Array ( [id] => 18362222 [patent_doc_number] => 20230143813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => Use of Ovatodiolide against SARS-CoV-2 [patent_app_type] => utility [patent_app_number] => 17/996226 [patent_app_country] => US [patent_app_date] => 2020-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7118 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996226 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996226
Use of Ovatodiolide against SARS-CoV-2 Apr 16, 2020 Issued
Array ( [id] => 16204698 [patent_doc_number] => 20200237688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => VESICULAR MONOAMINE TRANSPORTER-2 LIGANDS AND THEIR USE IN THE TREATMENT OF PSYCHOSTIMULANT ABUSE [patent_app_type] => utility [patent_app_number] => 16/846989 [patent_app_country] => US [patent_app_date] => 2020-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5483 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 254 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16846989 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/846989
VESICULAR MONOAMINE TRANSPORTER-2 LIGANDS AND THEIR USE IN THE TREATMENT OF PSYCHOSTIMULANT ABUSE Apr 12, 2020 Abandoned
Array ( [id] => 17393551 [patent_doc_number] => 11242554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-08 [patent_title] => Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes [patent_app_type] => utility [patent_app_number] => 16/844223 [patent_app_country] => US [patent_app_date] => 2020-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 32 [patent_no_of_words] => 17432 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16844223 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/844223
Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes Apr 8, 2020 Issued
Array ( [id] => 17731012 [patent_doc_number] => 11387414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-12 [patent_title] => Spirobifluorene compounds for organic electroluminescent devices [patent_app_type] => utility [patent_app_number] => 16/842522 [patent_app_country] => US [patent_app_date] => 2020-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14517 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842522 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/842522
Spirobifluorene compounds for organic electroluminescent devices Apr 6, 2020 Issued
Array ( [id] => 17319341 [patent_doc_number] => 20210408391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => N HETEROCYCLIC PLANAR PHOTOCOUPLER OUTPUT MATERIAL AND METHOD OF PREPARING THEREOF [patent_app_type] => utility [patent_app_number] => 16/762146 [patent_app_country] => US [patent_app_date] => 2020-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2572 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762146 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/762146
N heterocyclic planar photocoupler output material and method of preparing thereof Apr 1, 2020 Issued
Array ( [id] => 16176847 [patent_doc_number] => 20200223815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/834267 [patent_app_country] => US [patent_app_date] => 2020-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42219 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834267 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/834267
Indenyl compounds, pharmaceutical compositions, and medical uses thereof Mar 29, 2020 Issued
Array ( [id] => 17119622 [patent_doc_number] => 11130744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-28 [patent_title] => Indenyl compounds, pharmaceutical compositions, and medical uses thereof [patent_app_type] => utility [patent_app_number] => 16/834348 [patent_app_country] => US [patent_app_date] => 2020-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 33 [patent_no_of_words] => 42233 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834348 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/834348
Indenyl compounds, pharmaceutical compositions, and medical uses thereof Mar 29, 2020 Issued
Array ( [id] => 16348446 [patent_doc_number] => 20200313097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE [patent_app_type] => utility [patent_app_number] => 16/831696 [patent_app_country] => US [patent_app_date] => 2020-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18086 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 1245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831696 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/831696
Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device Mar 25, 2020 Issued
Array ( [id] => 16190743 [patent_doc_number] => 20200231592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => SUBSTITUTED 2-(4-HETEROCYCLYLBENZYL)ISOINDOLIN-1-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1 [patent_app_type] => utility [patent_app_number] => 16/823130 [patent_app_country] => US [patent_app_date] => 2020-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75681 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 475 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823130 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/823130
SUBSTITUTED 2-(4-HETEROCYCLYLBENZYL)ISOINDOLIN-1-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1 Mar 17, 2020 Abandoned
Array ( [id] => 16169418 [patent_doc_number] => 10710966 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-07-14 [patent_title] => Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof [patent_app_type] => utility [patent_app_number] => 16/818863 [patent_app_country] => US [patent_app_date] => 2020-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 29668 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818863 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/818863
Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof Mar 12, 2020 Issued
Array ( [id] => 17604010 [patent_doc_number] => 11332481 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Hole transporting material using dihydrophenazine as core and organic light emitting diode [patent_app_type] => utility [patent_app_number] => 16/652835 [patent_app_country] => US [patent_app_date] => 2020-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2447 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652835 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/652835
Hole transporting material using dihydrophenazine as core and organic light emitting diode Feb 13, 2020 Issued
Array ( [id] => 16565164 [patent_doc_number] => 10890529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-12 [patent_title] => Duplex stabilizing fluorescence quenchers for nucleic acid probes [patent_app_type] => utility [patent_app_number] => 16/788588 [patent_app_country] => US [patent_app_date] => 2020-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 32 [patent_no_of_words] => 23884 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788588 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/788588
Duplex stabilizing fluorescence quenchers for nucleic acid probes Feb 11, 2020 Issued
Array ( [id] => 19940297 [patent_doc_number] => 12312419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-27 [patent_title] => Hemiasterlin derivative having cysteine residue [patent_app_type] => utility [patent_app_number] => 17/429429 [patent_app_country] => US [patent_app_date] => 2020-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 29623 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 672 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429429 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/429429
Hemiasterlin derivative having cysteine residue Feb 11, 2020 Issued
Array ( [id] => 17603981 [patent_doc_number] => 11332452 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Pesticidal compositions and methods [patent_app_type] => utility [patent_app_number] => 17/263928 [patent_app_country] => US [patent_app_date] => 2020-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29563 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 369 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263928 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/263928
Pesticidal compositions and methods Jan 29, 2020 Issued
Array ( [id] => 17520449 [patent_doc_number] => 20220106298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => BIS(DIAZIRINE) DERIVATIVES AS PHOTO-CROSSSLINKER FOR TREATING CORNEAL ECTATIC DISORDERS [patent_app_type] => utility [patent_app_number] => 17/424413 [patent_app_country] => US [patent_app_date] => 2020-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29509 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -76 [patent_words_short_claim] => 354 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424413 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/424413
Bis(diazirine) derivatives as photo-crosslinker for treating corneal ectatic disorders Jan 23, 2020 Issued
Array ( [id] => 16686679 [patent_doc_number] => 20210069154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => Treatment of Breast Cancer [patent_app_type] => utility [patent_app_number] => 16/749133 [patent_app_country] => US [patent_app_date] => 2020-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22233 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16749133 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/749133
Treatment of Breast Cancer Jan 21, 2020 Abandoned
Array ( [id] => 16236645 [patent_doc_number] => 20200253879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR [patent_app_type] => utility [patent_app_number] => 16/746399 [patent_app_country] => US [patent_app_date] => 2020-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16746399 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/746399
Sustained release dosage forms for a JAK1 inhibitor Jan 16, 2020 Issued
Menu